Protriptyline
Above: molecular structure of protriptyline
Below: 3D representation of a protriptyline molecule | |
| Clinical data | |
|---|---|
| Trade names | Vivactyl, others |
| Other names | Amimethyline; Protriptyline hydrochloride; MK-240 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a604025 |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 77–93% |
| Protein binding | 92% |
| Metabolism | Hepatic |
| Elimination half-life | 54–92 hours |
| Excretion | Urine: 50% Feces: minor |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.474 |
| Chemical and physical data | |
| Formula | C19H21N |
| Molar mass | 263.384 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Protriptyline, sold under the brand name Vivactil among others, is a tricyclic antidepressant (TCA), specifically a secondary amine. Uniquely among most of the TCAs, protriptyline tends to be energizing instead of sedating, and is sometimes used for narcolepsy to achieve a wakefulness-promoting effect.
TCAs including protriptyline are also used to reduce the incidence of recurring headaches such as migraine, and for other types of chronic pain.